Phathom Pharmaceuticals

Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new treatments for gastrointestinal (GI) disorders. We have licensed the exclusive rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (PCAB) which the company is developing for the treatment of certain GI disorders.